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Objectives. To determine the seroprevalence of rubella virus 
infection among antenatal patients aged between 15 and 45 
years in the Western Cape province of South Africa, in order to 
provide data to determine the need for vaccination to protect 
women of childbearing age. 
Design. A cross-sectional study. 
Setting. Virology laboratory, Groote Schuur Hospital, National 
Health Laboratory Service (NHLS), South Africa. 
Subjects and methods. One thousand two hundred provincial 
serum specimens from participants in the 2003 Department of 
Health antenatal HIV /syphilis serosurvey were selected from 
the 4 districts of the Western Cape. The specimens were age-
stratified and screened qualitatively for rubellaimmunoglo-
bulin G (IgG) antibodies by means of a commercial 
immunoassay during October 2004. 
Rubella virus is a common cause of childhood fever and rash. 
It is of public health importance largely owing to the 
teratogenic effects of primary or secondary rubella infection in 
the first trimester of pregnancy.' Rubella acquired in the first 12 
weeks of pregnancy is associated with a nearly 90% risk of 
congenital malformations.2 A highly effective vaccine has been 
available since 1969 and vaccination programmes have 
eliminated or greatly reduced the incidence of rubella and 
congenital rubella syndrome (CRS) in developed countries.3 
Information on the epidemiology of rubella in South Africa is 
somewhat lacking. An article published in the December 1977 
issue of the SAM! by Kipps et al.' entitled 'The epidemiology of 
rubella in Cape Town' began as follows: 'Information on the 
epidemiology of rubella in the Republic of South Africa is 
woefully incomplete. The disease is not notifiable and there are 
no available reports of nationwide epidemics or of the 
incidence of congenital rubella infections in the general 
population.'' Regrettably little has changed in the subsequent 
28 years. Currently there is no national rubella immunisation 
programme, rubella is not notifiable, there are no surveillance 
programmes for congenital rubella, and the percentage of non-
immune women of childbearing age is largely unknown. The 
1977 study by Kipps et al. showed that 8.5% of females aged 
mJ between 15 and 25 years living in Cape Town were not 
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Results. Within the Western Cape a total o£95.3% of women in 
the 15- 24-year age group, 97.5% in the 25 - 34-year group and 
98% in the 35 - 45-year age group were immune to rubella. 
There was no statistically significant difference in the rate of 
rubella susceptibility between the 4 districts tested. 
Conclusions. The study is an important step in addressing the 
seroprevalence of rubella infection in women of childbearing 
age in South Africa. Further information is needed on rubella 
seroprevalence from the other provinces in South Africa as well 
as formal implementation of rubella and congenital rubella 
syndrome surveillance to determine the feasibility of routine 
rubella immunisation. 
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immune to rubella. A small study in 1983 from Tygerberg 
Hospital' showed that 10.5% of female hospital staff were 
susceptible to rubella. Data collected by Johnson et al.' in 1985 
from the former Witwatersrand area on random serum 
specimens submitted to the former National Institute for 
Virology showed that a worrying 18.4% of women of child-
bearing age were non-immune. In other developing countries 
the proportion of women of childbearing age susceptible to 
rubella varied from 4% in China to 70% in Trinidad and 
Tobago.' 
This study was prompted by a retrospective view which 
revealed that our virology laboratory at Groote Schuur 
Hospital confirmed 20 cases of congenital rubella syndrome 
over the 30 months from April 2002 to October 2004. In 
addition we are frequently asked to investigate cases of 
probable primary rubella or rubella reinfection in early 
pregnancy. Knowledge of rubella seroprevalence would allow 
one to model the incidence of CRS, thus providing an indirect 
measure of the burden of CRS. This is essential information for 
health policy makers when considering the inclusion of the 
rubella vaccine in the routine Expanded Programme for 
Immunisation in South Africa (EPI (SA)) schedule. We 
investigated the prevalence of immuno- globulin G (IgG) 
antibodies to rubella virus in 1 200 serum samples obtained 
from the 2003 Department of Health antenatal HIV I syphilis 
serosurvey within the Western Cape, South Africa.8 The present 
study is the first systematic study of rubella seroprevalence in 
pregnant women to have been performed in South Africa. 
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Materials and methods 
Study population 
One thousand two hundred provincial serum samples from 
participants in the 2003 Department of Health antenatal 
HIV I syphilis serosurvey were analysed for rubella IgG 
antibodies. These samples had been stored at -2ooc following 
testing for HIV and syphilis. The Western Cape covers an area 
of roughly 129 370 km' and has a population of approximately 
4.5 million people.' For the purposes of the annual antenatal 
survey the province is divided into 4 districts, namely the 
Metropolitan, West CoastiWinelands, South Coast/Klein 
Karoo and Boland/Overberg districts (Fig. 1). The Central 
Karoo district is not included in the Western Cape for the 
HIV I syphilis serosurvey and was therefore not included in this 
study. Three hundred anonymously collected serum specimens 
from women from each of the 4 districts were stratified 
according to age and tested for rubella IgG antibodies. The 
study was approved by the Research Ethics Committee of the 
University of Cape Town. 
Enzyme-linked immunosorbent assay (ELISA) for 
measuring antibodies to rubella 
Rubella-specific IgG antibodies were screened for qualitatively 
using a commercial immunoassay (Dade Behring, Marburg, 
Germany). The procedure and the interpretation of the results 
Fig. 1. Districts of the Western Cape as in the HIV /syphilis antenatal 
survey.' (Source: Migration Study in the Western Cape 2001, 
Provincial Government of the Western CapeY) 
were performed according to the manufacturer's instructions. 
Specimens with equivocal results were re-tested in duplicate. 
An optical density reading of> 0.2 at 450 nm was interpreted 
as positive for rubella IgG. Women with negative or equivocal 
results were regarded as being non-immune to rubella. 
Results 
A total of 1 200 serum specimens (300 from each district) were 
tested and included in the analysis. The combined results from 
all 4 districts tested are shown in Table I. 
Table I. Seroprevalence of rubella antibodies, Western 
Cape (excluding Central Karoo district) 
Age group Number Number 















93.33 - 96.88 
95.45 - 98.79 
94.96 - 99.45 
95.30 - 97.47 
The age-stratified results from each district are shown in 
Table II. Combining the results from the 4 districts, a total of 
95.3% of women in the 15- 24-year age group, 97.5% in the 25 -
34-year group and 98% in the 35 - 45-year age group were 
immune to rubella. Using the chi-square test no statistically 
significant difference in the rate of rubella susceptibility was 
found between the 4 districts tested. 
Discussion 
Rubella vaccine is not part of the EPI schedule in South Africa 
and rubella virus continues to circulate freely. This study 
shows that by the time women in the Western Cape reach 
childbearing age, taken to be 15 years, 95.3% are immune to 
rubella. Similar prevalence rates were seen in all 4 districts 
sampled. This study was not powered to assess differences in 
rubella susceptibility among different racial groups in the 
province or to look for 'pockets' of increased rubella-
susceptible women. At first glace the high level of immunity 
may seem reassuring; however, at the time of reaching 
childbearing age nearly 1 in 20 women in the Western Cape 
(4.7%) remain susceptible in an environment with freely 
circulating wild-type rubella. These patients are at substantial 
Table II. Seroprevalence of rubella immunity in the 4 districts tested 
Age West Coast/ 95% South Coast/ 95% 95% 
group Number Metropolitan 95% confidence Winelands confidence Klein confidence Boland confidence 
(yrs) tested (%) interval (%) (%) interval (%) Karoo (%) interval (%) (%) interval (%) 
15-24 150 141 (94.0) 88.92 - 97.22 142 (94.7) 89.76- 97.67 145 (96.7) 92.39 - 98.91 144 (96.0) 91.50- 98.52 
25-34 100 96 (96.0) 90.07- 98.90 97 (97.0) 91.48- 99.38 100 (100) 96.38 -100* 97 (97.0) 91.48-99.37 
35-45 50 48 (96.0) 86.29- 99.51 49 (98.0) 89.35- 99.95 49 (98.0) 89.35-99.95 50 (100) 92.90 -100* 
*One sided, 97.5% confidence interval. 
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risk of primary rubella infection. Although there was no 
statistically significant difference in rubella susceptibility 
between the age groups (p = 0.085), using the non-parametric 
test for trend the observable increase in rubella immunity from 
95.3% in the 15 - 24-year age group to 98% in the 35 - 45-year 
age group could be indicative of primary rubella infection 
occurring in women of childbearing age (p = 0.04). However, 
this interpretation is limited by the cross-sectional nature of the 
study. The data from this study are corroborated by data 
'mined' from Groote Schuur Hospital's infertility clinic, which 
showed a rubella susceptibility rate of 4.97% among 1 139 
patients screened from April 2002 to October 2004. These 
patients are routinely tested for immunity to rubella as part of 
their initial assessment. 
Rubella infections tend to occur in late spring/summer and 
our laboratory has seen a consistent peak in the number of new 
congenital rubella cases during the winter months (6- 9 
months after seasonal peaks). 
An additional point to consider is that exposed pregnant 
women with low-level immunity to rubella can be reinfected in 
the face of circulating wild-type rubella. The risk of fetal 
infection is approximately 8% following reinfection in the first 
16 weeks of pregnancy, but fetal malformations are rare.10 
Rubella vaccine has not been recommended for inclusion in 
the EPI in many developing countries because where sustained 
high coverage cannot be guaranteed, its introduction could 
paradoxically increase the number of susceptible young 
women by slowing but not interrupting virus transmission and 
thus shifting the age of first exposure into the reproductive 
years.n Private-sector MMR vaccination in South Africa creates 
the same potential hazard.' 
Vaccination, however, is the only way of preventing 
congenital rubella. Two vaccination strategies may be 
implemented. A selective vaccination programme prevents CRS 
by vaccinating adolescent girls and women while allowing 
rubella to continue circulating. Universal vaccination of 
children has the aim of eliminating both rubella and CRS and 
has been shown to be the more successful strategy. Initially a 
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combined approach would be the most prudent in South Africa 
as the impact on CRS prevention would be immediate. 
Before authorities can consider including rubella vaccine in 
the EPI (SA), more information is needed on rubella 
seroprevalence in women of childbearing age in other 
provinces in South Africa. In addition, formal rubella and CRS 
surveillance need to be implemented. This information will 
provide a more scientific foundation for recommending that 
rubella vaccine be included in the national schedule. The 
magnitude of congenital rubella is underappreciated in South 
Africa and a concerted effort needs to be made to provide the 
data that will assist in its control. Even with the limitations of 
this small cross-sectional study, it is an important step in 
addressing the issue of seroprevalence of rubella antibodies in 
South Africa and in beginning to deal with this public health 
problem. 
Many thanks to Andrew Boulle for assistance with the statistics, Jane 
Yeats for valuable suggestions, the Department of Health, and the 
women who participated in the antenatal survey. This work was 
funded by a grant from the Poliomyelitis Research Foundation. 
References 
1. Cutts FT, Robertson SE, Diaz-Ortega J~L, Samuel R. Burden of disease from congenital 
rubella syndrome. Bull World Health Organ 1997; 75 (1): 55-69. 
2. Best JM, O'Shea S, Tipples G, eta[. Interpretation of rubella serology in pregnancy- pitfalls 
and problems. BMJ 2002; 325: 147-148. 
3. l<i M, Youl Choi B, Kim M-H, Shin Y-J, Park 'f. Rubella scroprevalence in Korean Children. J 
Korean Med Sci 2003; 18:331-336. 
4. Kipps A, Moodie JW, Wynchank S, Hodgkiss M, Malan AF. The epidemiology of rube11a in 
Cape Town. 5 Afr Med J 1977; 52: 956-960. 
5. Donald PR, Berlyn PJ, Becker WB. Rubella immune status of female hospital personneL S Afr 
Med J 1983; 63:4. 
6. Johnson S, McAnemey JM, Schoub BD, Kidd AH. Laboratory monitoring of rubella. S Afr 
Med f1985; 67:721-723. 
7. Cutts FT, Vynnycky E. Modelling the incidence of congenHa1 rubella syndrome in developing 
countries. Tnt] Epidemiol1999; 28:1176-1184. 
8. Department of Health. Report: National HJV and Syphilis Antenatal Sera-Prevalence Survey in 
South Africa 2003. Pretoria, 2003. 
9. Census 1996 and 2001. Provincial Po-pulation Statistics in the Western Cape. Western Cape 
Provincial Government, December 2003: 4. 
10. Best JM, Banatvala JE. Rubella. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Principles 
and Practice of Clinical Virology. 4th ed. Chichester: John Wiley, 2000:387-418. 
11. Robertson SE, Cutts FT, Samuel R, Diaz-Ortega J-L. Vaccination against rubella. Bull World 
Health Organ 1997; 75(1): 69-81. 
12. Western Cape Provincial Goverment. Migration Study in the Western Cape 2001. Cape Town, 
2001. 
Accepted 4 May 2005. 
